Young adults, particularly at universities like the University of Kent, are facing a critical health risk as access to the Meningitis B vaccine remains limited. The vaccine, which has been available for infants since 2015, is not offered through the NHS to this age group, leaving many unprotected and raising concerns about healthcare equity at a time when university life could amplify potential outbreaks.